Stryker Corp. (NYSE:SYK) shares are down slightly this afternoon despite a reported upgrade of the stock by UBS from Neutral to Buy.
The UBS analysts also raised their price target for the medical device manufacturer to $70.00 from $62.00, suggesting a potential 13.3 percent gain based on SYK’s current price of $61.85 a share.